Patent Number | Patent Title | Company | Revoked Date | Oppositions |
---|---|---|---|---|
EP2527457B1 | Widespread Gene Delivery To Motor Neurons Using Peripheral Injection Of Aav Vectors | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS |
Dec, 2021
|
BEZZUBOVA
|
EP3377110B1 | Nanoparticles Based On Optionally Alkoxylated Poly(Alkyl Cyanoacrylates) Having A Defined Degree Of Polymerization | ABBVIE DEUTSCHLAND GMBH AND CO KG |
Dec, 2021
|
SINTEF TTO
|
EP3002298B1 | Anti-Factor Xi Monoclonal Antibodies And Methods Of Use Thereof | OREGON HEALTH SCIENCE UNIVERSITY |
Dec, 2021
|
MERCK SHARP & DOHME
|
EP3104844B1 | Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them | DRUGGABILITY TECHNOLOGIES IP HOLDCO LTD |
Dec, 2021
|
ALKERMES PHARMA IRELAND
|
EP3226829B1 | A Personal Care Cream Composition | UNILEVER PLC |
Dec, 2021
|
THE PROCTER & GAMBLE
|
EP1797886B1 | Immune Stimulation Using Chemically Modified Rna | CUREVAC AG |
Dec, 2021
|
KNIG SZYNKA TILMANN VON RENESSE
WEINZIERL
|
EP2872533B1 | Methods Of Assessing The Suitability Of Transduced T Cells For Administration | UNIVERSITY OF PENNSYLVANIA PENN |
Dec, 2021
|
PATENT BOUTIQUE
ZWICKER SCHNAPPAUF & PARTNER PATENTANWLTE PARTG MBB
|
EP2133365B1 | Compositions And Methods For The Treatment Of Infections And Tumors | HARVARD COLLEGE |
Dec, 2021
|
PFIZER
|
EP2598151B1 | Compositions For Treating Heartworm Infestation | CEVA SANTE ANIMALE SA |
Dec, 2021
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
|
EP2934455B1 | Combination Of Active Agents Comprising At Least One Essential Oil, One Cyclodextrin And One Liquid Fatty Substance And Composition Comprising It | LOREAL SA |
Dec, 2021
|
THE PROCTER & GAMBLE
|
EP2380581B1 | Muscle-Building Agent | MEGMILK SNOW BRAND CO LTD |
Nov, 2021
|
ARLA FOODS AMBA
FRESENIUS KABI DEUTSCHLAND
NUTRICIA
|
EP3045471B1 | Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation | FERRING BV |
Nov, 2021
|
MERCK SERONO
|
EP2680881B1 | Vaccination In Elderly Patients | CUREVAC AG |
Nov, 2021
|
STRAWMAN
|
EP1925282B1 | Low Density Cosmetic Formulations, Cosmetic Products Containing The Same And Methods Of Cosmetic Treatment Of Hair, And/Or Skin Using The Same | LOREAL SA |
Nov, 2021
|
HENKEL
|
EP3395338B1 | Rapid Dissolution Formulation Of Cinacalcet Hcl | AMGEN INC |
Nov, 2021
|
ACCORD HEALTHCARE
AECHTER
BETAPHARM ARZNEIMITTEL
BIOGARAN
GLENMARK PHARMACEUTICALS EUROPE
HGF
TEVA PHARMACEUTICAL INDUSTRIES
|
EP2460820B8 | Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
Nov, 2021
|
CEVA SANTE ANIMALE
ELANCO
LABORATORIOS HIPRA
|
EP2622971B1 | Method For Controlling The Digestive Coagulation Of Proteins | NUTRICIA NV |
Nov, 2021
|
ABBOTT LABORATORIES
FRESENIUS KABI DEUTSCHLAND
NESTEC
|
EP2724728B1 | Complexes Of Il-15 And Il-15R Alpha And Uses Thereof | NOVARTIS AG |
Nov, 2021
|
HGF
|
EP2344141B1 | Compositions Comrrising Amlodipine And Bisoprolol | EGYT GYOGYSZERVEGYESZETI GYAR |
Nov, 2021
|
KRKA
|
EP3143985B1 | Use Of Probiotic Microorganisms To Reduce Skin Irritation | SOCIETE DES PRODUITS NESTLE SA |
Nov, 2021
|
CHR HANSEN
LACBIOME
SOFAR
|
EP2324834B1 | Methods Of Increasing Endogenous Erythropoietin (Epo) | FIBROGEN INC |
Nov, 2021
|
AKEBIA THERAPEUTICS
|
EP2056845B1 | Structure And Use Of 5' Phosphate Oligonucleotides | RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN |
Nov, 2021
|
WITHERS & ROGERS
|
EP2278002B1 | Processes For The Manufacture Of Sterilized Pancreatin Powder | ABBOTT LABORATORIES GMBH |
Oct, 2021
|
NORDMARK ARZNEIMITTEL
|
EP2519300B1 | System For Treating Target Ti S Sue Within The Eustachian Tube | ACCLARENT INC |
Oct, 2021
|
SPIGGLE & THEIS MEDIZINTECHNIK
|
EP2760425B8 | Foam Oxidative Hair Colorant Composition With The Free-Base Of 1, 4-Diamino-2-Methoxmethyl Benzene | NOXELL CORP |
Oct, 2021
|
HENKEL
|
EP2803366B1 | Compositions For Treating Or Preventing Oxalate-Related Disease | OXTHERA INTELLECTUAL PROPERTY AB |
Oct, 2021
|
POHLMAN
|
EP2223688B1 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof | CELGENE CORP |
Oct, 2021
|
GALENICUM HEALTH SLU
HEXAL
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
ZENTIVA KS
|
EP3072499B1 | Octocrylene-Free Sunscreen With Low Adhesion | BEIERSDORF AG |
Oct, 2021
|
DALLI WERKE
DSM NUTRITIONAL PRODUCTS
LOREAL
|
EP1991267B1 | Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab | BIOGEN MA INC |
Oct, 2021
|
PHARMACEUTICAL WORKS POLPHARMA
|
EP3272397B1 | Agent For Oxidative Hair Dye And Method For Stabilizing Color Tone Of Oxidative Hair Dye Composition | HOYU CO LTD |
Oct, 2021
|
HENKEL
LOREAL
|
EP2859075B1 | Biosolubilizer | GIVAUDAN SA |
Oct, 2021
|
CRODA
EVONIK OPERATIONS
|
EP3054993B1 | Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna | HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH |
Oct, 2021
|
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
|
EP3210592B1 | Silica And Dentifrice Composition Comprising The Same | EVONIK DEGUSSA GMBH |
Oct, 2021
|
PQ PQ SILICAS UK
|
EP2925299B1 | Novel Pharmaceutical Composition | NOVARTIS AG |
Oct, 2021
|
GENERICS UK
|
EP2842569B1 | One Dose Vaccination With Mycoplasma Hyopneumoniae | ZOETIS SERVICES LLC |
Oct, 2021
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
|
EP2648520B1 | Dexmedetomidine Premix Formulation | HOSPIRA INC |
Oct, 2021
|
FRESENIUS KABI DEUTSCHLAND
|
EP2658546B1 | Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health | ABBOTT LABORATORIES |
Oct, 2021
|
SOCIT DES PRODUITS NESTL
|
EP2688561B1 | Transdermal Compositions Comprising An Active Agent Layer And An Active Agent Conversion Layer | TEIKOKU PHARMA USA INC |
Oct, 2021
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
|
EP2814450B1 | Stable Water-In-Oil Emulsions With Hlb-Type Emulsifiers | BEIERSDORF AG |
Sep, 2021
|
EVONIK OPERATIONS
|
EP3160428B1 | A Sebum-Promoting Agent For Improving Hair | UNILEVER PLC |
Sep, 2021
|
THE PROCTER & GAMBLE
|
EP2425821B1 | Pharmaceutical Preparation Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
Sep, 2021
|
ACINO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
GLENMARK PHARMACEUTICALS EUROPE
G L PHARMA
HEXAL SANDOZ
INTAS PHARMACEUTICALS
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
|
EP3461895B1 | Modulation Of Ube3A-Ats Expression | BAYLOR COLLEGE OF MEDICINE |
Sep, 2021
|
F HOFFMANN LA ROCHE
|
EP2190434B1 | Purin Derivatives For Use In The Treatment Of Fab-Related Diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
Sep, 2021
|
HEXAL
|
EP2768479B1 | Excipients For Nicotine-Containing Therapeutic Compositions | MODORAL BRANDS INC |
Sep, 2021
|
PHILIP MORRIS PRODUCTS
|
EP1622470B1 | Alginate Matrix Particles | GIVAUDAN SA |
Sep, 2021
|
OMYA
|
EP3233030B1 | Composition In The Form Of O/W Emulsion | LOREAL SA |
Sep, 2021
|
HENKEL
KAO GERMANY
|
EP2837407B1 | Octocrylene-Free, Odour-Stable Sun Protection Agent | BEIERSDORF AG |
Aug, 2021
|
BASF
DSM NUTRITIONAL PRODUCTS
LOREAL
|
EP2997134B1 | Human Application Of Engineered Chimeric Antigen Receptor (Car) T-Cells | UNIVERSITY OF TEXAS SYSTEM |
Aug, 2021
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
|
EP3395331B1 | Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine | ALFRED E TIEFENBACHER GMBH AND CO KG |
Aug, 2021
|
BLLE DR
|
EP2056832B1 | Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin Derivate | ASTRAZENECA AB |
Aug, 2021
|
GENERICS UK TRADING MYLAN
HEXAL BIOTECH
WITTKOPP
|
EP2674408B1 | Translucent Zirconia Sintered Body, Process For Producing The Same, And Use Of The Same | TOSOH CORP |
Aug, 2021
|
HOFFMANN EITLE
M DEUTSCHLAND DE M INNOVATIVE PROPERTIES
TREIBACHER INDUSTRIE
|
EP2788019B1 | Exosomes For Delivery Of Biotherapeutics | OXFORD UNIVERSITY INNOVATION LTD |
Aug, 2021
|
TRUSCOTT
|
EP3070090B1 | Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile | INCYTE HOLDINGS CORP |
Aug, 2021
|
GENERICS UK
|
EP3087098B1 | Anti-Vista Antibodies And Fragments | JANSSEN PHARMACEUTICA NV |
Aug, 2021
|
MARGARET DIXON
REGIMBEAU
|
EP2646003B1 | Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods | ADARE PHARMACEUTICALS INC |
Aug, 2021
|
DR FALK PHARMA
|
EP2448551B1 | Ester Mixtures And Compositions Comprising Such Ester Mixtures | COGNIS IP MANAGEMENT GMBH |
Aug, 2021
|
KADOR & PARTNER PARTG MBB
|
EP2854790B1 | Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media | ARES TRADING SA |
Aug, 2021
|
FERRING
|
EP2305711B1 | Methods For Treating Osteoarthitis Pain By Administering A Nerve Growth Factor Antagonist And Compositions Containing The Same | RINAT NEUROSCIENCE CORP |
Jul, 2021
|
REGENERON PHARMACEUTICALS
|
EP1845956B1 | Break-Resistant Delayed-Release Forms Of Administration | GRUENENTHAL GMBH |
Jul, 2021
|
G L PHARMA
|
EP3024461B1 | A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation | EURO CELTIQUE SA |
Jul, 2021
|
DEVELCO PHARMA SCHWEIZ
HEXAL PHARMA
|
EP2836196B1 | Preparation For Topical Application To Mucosa Containing Polyhexanide As Active Ingredient | MERZ PHARMA GMBH AND CO KGAA |
Jul, 2021
|
MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
|
EP2962686B1 | Dosage Form Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
Jul, 2021
|
ARISTO PHARMA
DEVELCO PHARMA SCHWEIZ
ETHYPHARM
HEXAL SANDOZ
KRKA
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
|
EP2797570B1 | Antiperspirant Aerosol Preparations With Reduced Textile Staining | BEIERSDORF AG |
Jul, 2021
|
THE PROCTER & GAMBLE
|
EP2970677B1 | Small Scale Microencapsulated Pigments And Uses Thereof | CHROMATIC TECHNOLOGIES INC |
Jul, 2021
|
SOCIT BIC
|
EP2863876B1 | Hair Colorant Compositions Comprising 2-Methoxymethyl-1,4-Diaminobenzene, Methods, And Kits | NOXELL CORP |
Jul, 2021
|
HENKEL
|
EP3179989B1 | Silicone-Containing Acrylic Polymers For Transdermal Drug Delivery Compositions | NOVEN PHARMACEUTICALS INC |
Jul, 2021
|
LTS LOHMANN THERAPIE SYSTEME
|
EP2494983B1 | Stable Formulations Of Glp-1 | NOVO NORDISK AS |
Jul, 2021
|
HGF
HOFFMANN EITLE
|
EP2214679B1 | Corticosteroid Compositions | MERITAGE PHARMA INC |
Jun, 2021
|
AECHTER
DR FALK PHARMA
|
EP2861234B1 | Progesterone Formulations | THERAPEUTICSMD INC |
Jun, 2021
|
RIECK
|
EP2945628B1 | Androgen Receptor Modulator And Uses Thereof | ARAGON PHARMACEUTICALS INC |
Jun, 2021
|
GENERICS UK
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
SYNTHON
TEVA PHARMACEUTICAL INDUSTRIES
|
EP3222266B1 | Compositions And Methods For Targeted Thermomodulation | SIENNA BIOPHARMACEUTICALS INC |
Jun, 2021
|
SEBACIA
|
EP1317918B1 | Cosmetic Sunscreen Compositions Based On Synergistic Filter Mixture And Their Use | LOREAL SA |
Jun, 2021
|
STADA ARZNEIMITTEL
|
EP2289352B1 | Agent For Use In The Case Of Fructose Intolerance | VITACARE GMBH AND CO KG |
Jun, 2021
|
STADA ARZNEIMITTEL
|
EP3060303B1 | Mrna Therapy For Argininosuccinate Synthetase Deficiency | TRANSLATE BIO INC |
Jun, 2021
|
WITHERS & ROGERS
|
EP3027174B1 | Pharmaceutical Compositions Of Fingolimod | AIZANT DRUG RES SOLUTIONS PRIVATE LTD |
Jun, 2021
|
DF MP DRRIES FRANK MOLNIA & POHLMAN
|
EP3065731B1 | Methods And Compositions For Improving Kidney Function | HILLS PET NUTRITION INC |
Jun, 2021
|
IAMS EUROPE
|
EP3307393B1 | Fragrance Composition | PROCTER AND GAMBLE CO |
May, 2021
|
HENKEL
|
EP2797581B1 | Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione | AMGEN EUROPE GMBH |
May, 2021
|
GALENICUM HEALTH SLU
GENERICS UK
KRKA
|
EP3236938B1 | Oral Topical Aqueous Pharmaceutical Compositions Of Flurbiprofen And Dexpanthenol | SANOVEL ILAC SANAYI VE TICARET AS |
May, 2021
|
RECKITT BENCKISER HEALTH
|
EP3127427B1 | Methods Of Administration Of Thrombopoietin Agonist Compounds | NOVARTIS AG |
May, 2021
|
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA KS
|
EP2711024B1 | Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same | UNITED THERAPEUTICS CORP |
May, 2021
|
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
|
EP2794014B1 | Product For Temporarily Shaping Keratin Fibers On The Basis Of A Combination Of Specific Film-Forming Polymers | HENKEL AG AND CO KGAA |
May, 2021
|
LOREAL
|
EP2773338B1 | Improving Recognition | NUTRICIA NV |
May, 2021
|
SOCIT DES PRODUITS NESTL
|
EP1617823B1 | A Composition Material For Transmucosal Delivery | NICACHET AB |
May, 2021
|
KELTIE
|
EP2649982B1 | Hair Bleaching Composition And Method For Producing Same | ARTEC CHEMICAL CO LTD |
May, 2021
|
KAO GERMANY
LOREAL
|
EP3075744B1 | Improved Recombinant Human Follicle-Stimulating Hormone | GLYCOTOPE GMBH |
May, 2021
|
AUGUST DEBOUZY
|
EP3209387B1 | Chitosan-Containing Antiperspirant Cosmetic Agents Which Are Free Of Halides And/Or Hydroxy Halides Of Aluminum And/Or Zirconium | HENKEL AG AND CO KGAA |
Apr, 2021
|
THE PROCTER & GAMBLE
|
EP3093009B1 | Octocrylene-Free Sunscreen Agent With Diethylaminohydroxybenzoylhexylbenzoate | BEIERSDORF AG |
Apr, 2021
|
DALLI WERKE
EMIL KIESSLING
LOREAL
MIBELLE
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
|
EP3116527B1 | Method For Preparing Human Plasma Proteins | LFB SA |
Apr, 2021
|
CSL BEHRING
|
EP3058958B1 | Anidulafungin Composition | SELECTCHEMIE AG |
Apr, 2021
|
COOKE
|
EP3027063B1 | Glyceride Composition | BUNGE LODERS CROKLAAN BV |
Apr, 2021
|
FRUTAROM
NEDERLANDSCH OCTROOIBUREAU
|
EP3000805B1 | C7-Fluoro Substituted Tetracycline Compounds | TETRAPHASE PHARMACEUTICALS INC |
Apr, 2021
|
SANDOZ
|
EP1846030B1 | Fixed Dosing Of Her Antibodies | GENENTECH INC |
Apr, 2021
|
BREUER
DR H ULRICH DRRIES
KNIG SZYNKA TILMANN VON RENESSE
LEEMING
|
EP3030666B1 | Compositions And Methods For Treatment Of Muscular Dystrophy | CONSIGLIO NAZIONALE DELLE RICHERCHE CNR |
Apr, 2021
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
|
EP2337849B1 | Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production | UNIQURE BIOPHARMA BV |
Mar, 2021
|
BAXALTA
GREAVES BREWSTER
PFIZER
STRAWMAN
WEINZIERL
|
EP2680885B8 | Combination Vaccines With Lower Doses Of Antigen And/Or Adjuvant | GLAXOSMITHKLINE BIOLOGICALS SA |
Mar, 2021
|
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
|
EP2822383B1 | Antimicrobial Compostion Containing Lauric Acid And Method For Their Production | CARGILL INC |
Mar, 2021
|
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
NUTRITION SCIENCES
|
EP3033079B1 | Methods For The Treatment Of Her2 Amplified Cancer | PHARMACYCLICS LLC |
Mar, 2021
|
GENERICS UK
|
EP2658509B1 | Hair Colouring Composition | KAO GERMANY GMBH |
Mar, 2021
|
HENKEL
|
EP3112377B1 | Bifunctional Polypeptides | IMMUNOCORE LTD |
Mar, 2021
|
MICHALSKI HTTERMANN & PARTNER PATENTANWLTE MBB
|
EP3248600B8 | Combinations And Modes Of Administration Of Therapeutic Agents And Combination Therapy | ABRAXIS BIOSCIENCE LLC |
Mar, 2021
|
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
|
EP1784222B1 | Nutritional Composition Comprising Indigestible Oligosaccharides | NUTRICIA NV |
Mar, 2021
|
SOCIT DES PRODUITS NESTL
|
EP2374472B9 | Compositions And Methods For Treating Ophthalmic Disorders | DYAX CORP |
Mar, 2021
|
BICYCLETX
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
OXURION
|
EP2822591B1 | Pharmaceutical Formulations Of Tnf-Alpha Antibodies | CADILA HEALTHCARE LTD |
Mar, 2021
|
BOULT WADE TENNANT
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
|
EP2670429B1 | Method For Inactivation/Removal Of Coagulation Factors By Precipitation | OCTAPHARMA AG |
Mar, 2021
|
BIOTEST
STRAWMAN
|
EP3261485B1 | Cosmetic Product Having A Metal Can, And The Contents Of Same | BEIERSDORF AG |
Mar, 2021
|
HENKEL
|
EP2773334B1 | Composition With Sustained Antimicrobial Activity | COLUMBIA UNIVERSITY OF NEW YORK |
Feb, 2021
|
HENKEL
|
EP2346355B1 | Nutritional Compositions With Lipid Globules With A Core Comprising Vegetable Lipids And A Coating Comprising Phospholipids Or Polar Lipids | NUTRICIA NV |
Feb, 2021
|
FRESENIUS KABI DEUTSCHLAND
|
EP3093005B1 | Octocrylene-Free Sunscreen Comprising Diethyl Hexyl Butamido Triazone | BEIERSDORF AG |
Feb, 2021
|
DALLI WERKE
DSM NUTRITIONAL PRODUCTS
EMIL KIESSLING
LOREAL
MIBELLE
PLOUGMANN VINGTOFT
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
|
EP3195853B1 | Octocrylene-Free Solar Protection Formulation With Diethylamino Hydroxybenzoyl Hexyl Benzoate. | BEIERSDORF AG |
Feb, 2021
|
EMIL KIESSLING
|
EP2486141B1 | Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use | MACROGENICS INC |
Feb, 2021
|
ISENBRUCK BSL HRSCHLER
STRAWMAN
|
EP2968221B1 | Pharmaceutical Composition Of S-Ketamine Hydrochloride | JANSSEN PHARMACEUTICA NV |
Jan, 2021
|
ASPIRE PHARMA
SANDOZ
|
EP2850189B8 | Compositions And Methods For Modulating Gene Expression | GENERAL HOSPITAL CORP |
Jan, 2021
|
ROCHE INNOVATION CENTER COPENHAGEN
|
EP2345425B1 | Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs | LFB SA |
Jan, 2021
|
OCTAPHARMA
TAKEDA PHARMACEUTICALS
|
EP3167900B1 | Vaccine Against Streptococci | MERIAL LTD |
Jan, 2021
|
AWA SWEDEN
|
EP3112376B1 | Bifunctional Polypeptides | IMMUNOCORE LTD |
Jan, 2021
|
STORZ
|